A股異動 | 國際醫學(000516.SZ)漲逾4% 攜手泰格醫藥聚焦醫藥醫療產業平台深度融合
格隆匯6月17日丨國際醫學(000516.SZ)漲逾4%,報19.97元,年內累計漲幅近60%,總市值455億元。國際醫學昨晚公吿與泰格醫藥簽訂戰略合作協議。公司表示,為積極響應“健康中國2030戰略”,促進大健康事業發展,雙方整合各自優勢產業資源,聚焦醫藥醫療產業平台的深度融合,推動“醫、教、研、產、投”協同,打造醫療產業高質量發展創新模式。雙方以共同合作進行藥物臨牀試驗與開發為契機,全面啟動雙方戰略合作,並進一步拓展合作廣度和深度。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.